[ad_1]
Drugmaker Zydus Cadila said on Friday it signed a non-exclusive agreement with Gilead Sciences Inc to manufacture and market antiviral drug remdesivir, the first treatment to show improvement in COVID-19 trials.
[ad_2]
Source link
Copyright 2014-2024 © Search My Business :: Kingson Information Technologies, All Rights Reserved.
